Stay updated on SKI-G-801 Dose Study in AML Clinical Trial
Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed in the study's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the notice that information may be outdated due to a lapse in government funding, including references to cc.nih.gov and opm.gov for operating status.SummaryDifference0.4%

- Check34 days agoChange DetectedThe update appears to be a UI redesign and minor textual edits on the Study Details pages; core data like eligibility criteria, study outcomes, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference4%

- Check69 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1); a minor UI element, 'Back to Top', was removed.SummaryDifference0.2%

Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.